Earnings History Data for Cocrystal Pharma (COCP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of HepC. Phase 1b studies in HepC infected patients showed the largest reduction in viral load of any non-nucleoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 6 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the Company has a pipeline of promising early preclinical programs. Two private investors own approximately 48% of the Company.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-03-2024 | PM | COCP | Cocrystal Pharma | 15.00 | -0.44 | -0.57 | 0.00 | Cocrystal Pharma GAAP EPS of -$1.87 [3/28/2024 2:47 PM] |
1.41 | -0.09 (-6.00%) |
0.0 | 0.0 (0.00%) |
1.33 - 3.29 | 78,986 | 10,000 | 0 | ||
| 14-08-2023 | PM | COCP | Cocrystal Pharma | 30.00 | -0.50 | -0.53 | 0.00 | Cocrystal Pharma GAAP EPS of -$0.50 [8/14/2023 1:54 PM] |
3.06 | 0.17 (5.71%) |
0.0 | 0.0 (0.00%) |
1.74 - 6.24 | 38,223 | 50,000 | 0 | ||
| 15-05-2023 | PM | COCP | Cocrystal Pharma, Inc. | 25.54 | -0.64 | -0.59 | -0.48 | Cocrystal Pharma GAAP EPS of -$0.64 misses by $0.05 [5/15/2023 9:58 AM] |
2.55 | 0.04 (1.59%) |
0.0 | 0.0 (0.00%) |
1.74 - 6.24 | 31,552 | 40,000 | 0 | ||
|
|
||||||||||||||||||
| 11-05-2022 | PM | COCP | Cocrystal Pharma | 40.00 | -0.04 | -0.04 | 0.00 | Cocrystal Pharma GAAP EPS of -$0.04 in-line [5/11/2022 8:09 AM] |
0.3863 | -0.01 (-3.45%) |
0.41 | 0.0 (1.22%) |
0.37 - 1.49 | 279,100 | 260,000 | 3,883 | ||
| 16-08-2021 | PM | COCP | Cocrystal Pharma, Inc. | 104.00 | -0.04 | -0.04 | 0.00 | Cocrystal Pharma EPS in-line [8/16/2021 8:41 AM] |
0.9998 | -0.03 (-2.93%) |
1.03 | 0.0 (0.00%) |
0.76 - 3.46 | 2,721,646 | 2,280,000 | 95,751 | ||
| 17-05-2021 | PM | COCP | Cocrystal Pharma, Inc. | 77.00 | -0.04 | -0.04 | 0.00 | Cocrystal Pharma EPS in-line [5/17/2021 8:33 AM] |
1.13 | 0.0 (0.00%) |
1.14 | 0.01 (0.88%) |
0.76 - 3.46 | 3,668,299 | 89,400,000 | 145,746 | ||
| 16-11-2020 | PM | COCP | Cocrystal Pharma, Inc. | 59.60 | -0.05 | -0.05 | -0.06 | Cocrystal Pharma misses on revenue [11/16/2020 8:30 AM] |
0.8530 | 0.01 (0.88%) |
0.8250 | -0.02 (-2.44%) |
0.39 - 3.04 | 579,478 | 734,080 | 16,521 | ||
|
|
||||||||||||||||||